Skip to main content
editorial
. 2022 Jan;11(1):100–110. doi: 10.21037/tlcr-21-1039

Figure 2.

Figure 2

Identification and validation of the huntingtin-interacting protein 1 (HIP1)-anaplastic lymphoma kinase (ALK) fusion in a NSCLC patient. (A) DNA sequencing reads of HIP1 and ALK were visualized by the Integrative Genomics Viewer (IGV); (B) RNA sequencing reads of HIP1 and ALK were visualized by the Integrative Genomics Viewer (IGV); (C) a schematic map showing the structure of the HIP1-ALK fusion locus. NSCLC, non-small cell lung cancer.